Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Diagnosis of Lung Cancer With Radiolabeled hJAA-F11

NCT06427369 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT06427369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06427369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Diagnosis of Lung Cancer With Radiolabeled hJAA-F11
Lead sponsor
Roswell Park Cancer Institute
Phase
Phase 1
Overall status
Withdrawn
Start date
October 1, 2024
Completion date
September 1, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

extensive-stage small-cell lung cancer, limited-stage small-cell lung cancer, lung non-small cell carcinoma, stage iiia lung cancer, stage iv lung cancer